With the Veris Cancer Care Platform, cancer care teams at the New Jersey Cancer Care, PA can now review patients’ physiologic and clinical data in real time and deliver personalized care.WHY IT MATTERS
Today, NJCC…
What You Should Know:– Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others…
Continue Reading
Each person is unique in how they react to prescription and over-the-counter medications. Factors like genetics and other medications you take can affect how you metabolize and respond to certain drugs. Understanding these factors…
Continue Reading
Sequencing our 3.2 billion DNA base pairs is becoming increasingly crucial as genomic testing gains widespread acceptance. Advancements in genomics are improving the detection of mutations that can lead to illnesses, with the potential to revolutionize personalized medicine by enabling the development of more effective treatments for genetic disorders. High-performance computing is revolutionizing the field of genomics by accelerating the speed of analysis and processing of large-scale gene sequencing data sets. However, genomics is facing a massive Big Data problem. Scientists are struggling to process a growing volume of data as precision medicine turns to gene sequencing for individual patients….
Continue Reading
Precision Health Can Be Applied to All DisciplinesThe University of California, Irvine, has integrated its technology to create targeted health and wellness strategies for patients. In February 2022, the university launched the Institute for Precision Health, an interdisciplinary campuswide initiative to develop solutions in precision medicine. A future brick-and-mortar home for IPH will let data scientists collaborate with clinicians to develop analytics tools.
“Precision health is truly an amalgamation of multiple critical pillars. Understanding the multidisciplinary nature of this work is really how IPH came about,” says Dr. Peter Chang, assistant professor in residence at UCI’s Department of Radiological Sciences. He formed…
